Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-27 Purchase | 2026-03-03 5:35 pm | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 900,000 | $14.1 | $12,688,806 | 12,229,500 (Indirect) | View |
| 2025-08-01 Purchase | 2025-08-05 5:31 pm | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 1,300,000 | $10.45 | $13,590,000 | 11,329,500 (Indirect) | View |
| 2025-08-01 Sale | 2025-08-05 4:07 pm | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer | 20,000 | $10.5 | $210,000 | 133,484 (Direct) | View |
| 2025-03-07 Sale | 2025-03-07 5:25 pm | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer | 8,305 | $8.23 | $68,350 | 153,484 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 9:02 pm | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 360,540 | $7.9634 | $2,871,124 | 2,232,918 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 8:59 pm | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer | 12,239 | $8 | $97,912 | 257,359 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 8:58 pm | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 118,013 | $7.9619 | $939,612 | 701,754 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 8:57 pm | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 122,479 | $7.9624 | $975,223 | 637,714 (Direct) | View |
| 2025-03-03 Sale | 2025-03-04 8:56 pm | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 124,893 | $7.9622 | $994,425 | 806,881 (Direct) | View |
| 2025-02-28 Purchase | 2025-03-04 5:03 pm | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 1,600,000 | $7.9457 | $12,713,126 | 10,029,500 (Indirect) | View |
| 2024-12-05 Purchase | 2024-12-09 4:52 pm | Aurinia Pharmaceuticals Inc. | AUPH | TANG KEVIN Director | 1,200,000 | $9.0183 | $10,822,000 | 8,429,500 (Indirect) | View |
| 2024-11-11 Sale | 2024-11-12 7:29 pm | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 4,557 | $8.43 | $38,416 | 13,356 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 7:20 pm | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 5,241 | $8.43 | $44,182 | 12,672 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-27 Option Award | 2026-03-03 4:14 pm | N/A 2036-02-27 | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 152,929 | $0 | 672,121 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:14 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 37,511 | $14.21 | 672,121 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:14 pm | N/A 2036-02-27 | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 155,416 | $0 | 777,555 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:14 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 40,761 | $14.21 | 777,555 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:13 pm | N/A 2036-02-27 | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 524,827 | $0 | 2,168,803 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:13 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 100,890 | $14.21 | 2,168,803 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:13 pm | N/A 2036-02-27 | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg SVP, Chief Medical Officer | 108,456 | $0 | 230,388 (Direct) | View |
| 2026-02-27 Option Award | 2026-03-03 4:12 pm | N/A 2036-02-27 | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 157,903 | $0 | 604,674 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 4:12 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 36,525 | $14.21 | 604,674 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-23 4:08 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 32,901 | $14.4 | 662,900 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-23 4:07 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 100,171 | $14.4 | 1,744,866 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-23 4:05 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 32,424 | $14.4 | 556,703 (Direct) | View |
| 2026-02-20 Tax Withholding | 2026-02-23 4:04 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 34,638 | $14.4 | 483,296 (Direct) | View |
| 2026-02-02 Tax Withholding | 2026-02-03 4:49 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg SVP, Chief Medical Officer | 11,552 | $14.53 | 121,932 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:13 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 48,558 | $0 | 517,934 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:13 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 40,385 | $15.95 | 517,934 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:12 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 54,166 | $0 | 695,801 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:12 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 42,787 | $15.95 | 695,801 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:11 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 49,038 | $0 | 589,127 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:11 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 40,161 | $15.95 | 589,127 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-05 4:10 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 165,384 | $0 | 1,845,037 (Direct) | View |
| 2026-01-02 Tax Withholding | 2026-01-05 4:10 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 113,169 | $15.95 | 1,845,037 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 5:19 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 2,716 | $15.68 | 22,775 (Direct) | View |
| 2025-11-21 Tax Withholding | 2025-11-24 5:17 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Johnson Craig A Director | 6,039 | $15.68 | 14,592 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-16 5:06 pm | N/A 2035-05-16 | Aurinia Pharmaceuticals Inc. | AUPH | Nova Tina Susan Director | 63,724 | $0 | 63,724 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-16 5:05 pm | N/A 2035-05-16 | Aurinia Pharmaceuticals Inc. | AUPH | Johnson Craig A Director | 37,485 | $0 | 37,485 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-16 5:04 pm | N/A 2035-05-16 | Aurinia Pharmaceuticals Inc. | AUPH | Goetz Kathleen Director | 63,724 | $0 | 63,724 (Direct) | View |
| 2025-05-16 Option Award | 2025-05-16 5:04 pm | N/A 2035-05-16 | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 37,485 | $0 | 37,485 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 9:02 pm | N/A 2035-02-28 | Aurinia Pharmaceuticals Inc. | AUPH | Greenleaf Peter Chief Executive Officer | 1,068,406 | $0 | 2,232,918 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 8:59 pm | N/A 2035-02-28 | Aurinia Pharmaceuticals Inc. | AUPH | Keenan Greg Chief Medical Officer | 158,153 | $0 | 257,359 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 8:58 pm | N/A 2035-02-28 | Aurinia Pharmaceuticals Inc. | AUPH | Miller Joseph M Chief Financial Officer | 320,561 | $0 | 701,754 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 8:57 pm | N/A 2035-02-28 | Aurinia Pharmaceuticals Inc. | AUPH | Robertson Stephen P. EVP, General Counsel | 314,950 | $0 | 637,714 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 8:56 pm | N/A 2035-02-28 | Aurinia Pharmaceuticals Inc. | AUPH | Donley Matthew Maxwell Chief Operating Officer | 344,764 | $0 | 806,881 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:38 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 30,776 | $0 | 43,448 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:36 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Leversage Jill Director | 30,776 | $0 | 43,694 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:33 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Johnson Craig A Director | 52,319 | $0 | 52,319 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:30 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 30,776 | $0 | 44,132 (Direct) | View |
| 2024-11-21 Option Award | 2024-11-25 4:28 pm | N/A 2034-11-21 | Aurinia Pharmaceuticals Inc. | AUPH | Jayne David R.W. Director | 30,776 | $0 | 75,140 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 7:29 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Bailey Jeffrey Allen Director | 17,913 | $0 | 13,356 (Direct) | View |
| 2024-11-08 Exercise | 2024-11-12 7:20 pm | N/A N/A | Aurinia Pharmaceuticals Inc. | AUPH | Smith Karen L. Director | 17,913 | $0 | 12,672 (Direct) | View |